SS
Sajal Singhal
About Sajal Singhal
Data last updated:
Sajal Singhal is a Director at Gastomach Pharmaceuticals Private Limited (since 2023) and Director at Endoshine Pharmaceuticals Private Limited (since 2021). The companies operate in Trading and E-Commerce. The 2 current companies with reported revenue have a combined latest revenue of ₹35.8 Lakh; the largest is Gastomach Pharmaceuticals Private Limited at ₹35.6 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gastomach Pharmaceuticals Private Limited U51909DL2020PTC361946 | Director | 23 Jun 2023 | 2020 | ₹35.6 Lakh (FY 2025) | Active |
| Endoshine Pharmaceuticals Private Limited U52590DL2021PTC383359 | Director | 07 Jul 2021 | 2021 | ₹22,100 (FY 2022) | Active |
Board colleagues of Sajal Singhal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Parul Gupta | 10211288 | Gastomach Pharmaceuticals Private Limited | Director |
| Rahul Singhal | 03612702 | Gastomach Pharmaceuticals Private Limited , Endoshine Pharmaceuticals Private Limited | Director |
| Vishal Gupta | 08701399 | Gastomach Pharmaceuticals Private Limited | Director |
| Vikas Chaudhary | 10832747 | Endoshine Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sajal Singhal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sajal Singhal
Sajal Singhal currently holds 2 directorships: Gastomach Pharmaceuticals Private Limited (Director, since 23 Jun 2023, revenue ₹35.6 Lakh (FY 2025)); Endoshine Pharmaceuticals Private Limited (Director, since 07 Jul 2021, revenue ₹22,100 (FY 2022)).
Sajal Singhal was first appointed on 07 Jul 2021 as Director at Endoshine Pharmaceuticals Private Limited. The most recent appointment on record is 23 Jun 2023 at Gastomach Pharmaceuticals Private Limited.
The 2 current companies of Sajal Singhal that report revenue have a combined latest revenue of ₹35.8 Lakh: Gastomach Pharmaceuticals Private Limited ₹35.6 Lakh (FY 2025); Endoshine Pharmaceuticals Private Limited ₹22,100 (FY 2022).
The current boards of Sajal Singhal's companies include Parul Gupta (Gastomach Pharmaceuticals Private Limited), Rahul Singhal (Gastomach Pharmaceuticals Private Limited), Vishal Gupta (Gastomach Pharmaceuticals Private Limited), Vikas Chaudhary (Endoshine Pharmaceuticals Private Limited).